Second Line Capital’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$287K Sell
721
-64
-8% -$28K 0.05% 125
2026
Q1
$359K Buy
785
+169
+27% +$85.5K 0.07% 112
2025
Q4
$349K Buy
616
+30
+5% +$16K 0.07% 99
2025
Q3
$262K Buy
586
+66
+13% +$31.7K 0.05% 126
2025
Q2
$283K Buy
520
+93
+22% +$48.6K 0.07% 111
2025
Q1
$211K Sell
427
-151
-26% -$83.5K 0.05% 136
2024
Q4
$302K Buy
578
+19
+3% +$9.9K 0.08% 92
2024
Q3
$275K Buy
559
+5
+0.9% +$2.33K 0.07% 98
2024
Q2
$246K Sell
554
-31
-5% -$12.3K 0.08% 93
2024
Q1
$233K Buy
+585
New +$221K 0.08% 99

Other funds holding ISRG

Second Line Capital's ISRG Position: Q2 2026 in Review

Second Line Capital reduced its Intuitive Surgical (ISRG) stake by 8.2% in Q2 2026, selling an estimated $28K and leaving 721 shares worth $287K. The position accounts for 0.05% of the portfolio, ranked #125.

Second Line Capital first reported a position in ISRG in Q1 2024 and has held it in 10 quarters since. The position peaked at $359K in Q1 2026. 2,249 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Second Line Capital held 721 shares of Intuitive Surgical worth $287K as of Q2 2026.
  • Second Line Capital sold 64 Intuitive Surgical shares in Q2 2026, an estimated $28K.
  • Intuitive Surgical made up 0.05% of Second Line Capital's portfolio in Q2 2026, its #125 holding.
  • Second Line Capital first reported a position in Intuitive Surgical in Q1 2024 and has held it in 10 quarters since.
  • Second Line Capital's Intuitive Surgical position peaked at $359K in Q1 2026.
  • 2,249 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Second Line Capital's 13F filing for Q2 2026, filed 12 Aug 2026.